The St. Gallen Consensus Session: loco-regional treatment

Highlights from BCC 2021: loco-regional management of the axillaПодробнее

Highlights from the St. Gallen Consensus PanelПодробнее

Key takeaways from the St. Gallen Consensus PanelПодробнее

Key debates from the St Gallen Expert ConsensusПодробнее

Key topics at St. Gallen 2021Подробнее

St. Gallen Consensus highlights: ovarian suppression, oligometastatic disease and radiotherapyПодробнее

St. Gallen international consensus on the optimal primary treatment of women with breast cancerПодробнее

Key updates from the St Gallen Consensus SessionПодробнее

St. Gallen Consensus 2021: neoadjuvant and adjuvant therapy for HER2+ breast cancerПодробнее

Hot topics at St Gallen BCCПодробнее

Systemic therapy at the St Gallen Consensus: multi-gene testing, Ki67, and oligometastatic diseaseПодробнее

St Gallen BCC 2023 highlightsПодробнее

Highlights from St. Gallen BCC 2023Подробнее

St. Gallen BCC: reaching an international consensusПодробнее

Loco-regional management after neoadjuvant chemotherapyПодробнее

St. Gallen BCC 2023 highlightsПодробнее

St Gallen 2023: de-escalation, personalized treatment & adjuvant IO following neoadjuvant IOПодробнее

St. Gallen BCC 2023: translating clinical developmentsПодробнее

Breast Cancer: From Diagnosis to Loco-Regional TreatmentПодробнее